Eli Lilly lowers full-year earnings outlook
April 24, 2014 at 08:35 AM EDT
Eli Lilly feels more strain from patent expirations for some of its bigger-selling drugs as first-quarter profit falls 53%.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|